• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光敏感性是神经元蜡样质脂褐质沉积症 2 型疾病的早期标志物。

Photosensitivity is an early marker of neuronal ceroid lipofuscinosis type 2 disease.

机构信息

Department of Neuroscience, Bambino Gesù Children's Hospital, IRCCS (Istituto di Ricerca e Cura a Carattere Scientifico), Rome, Italy.

Pediatric Neurology, 12 October University Hospital, Madrid, Spain.

出版信息

Epilepsia. 2017 Aug;58(8):1380-1388. doi: 10.1111/epi.13820. Epub 2017 Jun 20.

DOI:10.1111/epi.13820
PMID:28632327
Abstract

OBJECTIVE

This study aimed to identify early clinical, magnetic resonance imaging (MRI), and electroencephalographic (EEG) characteristics of neuronal ceroid lipofuscinosis type 2 (CLN2) disease to enable early diagnosis, thus providing the key to early treatment, and optimized care and outcomes.

METHODS

Retrospective clinical chart review of a series of patients diagnosed with CLN2 disease from 2005 to 2015 at a single center in Italy. Clinical, MRI, and EEG findings were reviewed.

RESULTS

A total of 14 patients were included. For the whole group, median (range) age at disease onset was 3.0 (2.0-3.8) years. Epilepsy was the most commonly reported presenting symptom (in 50% [seven of 14] of patients), occurring at the age of 3.2 (2.6-3.8) years. First seizure was myoclonic in 36% (five of 14) of patients, followed by generalized tonic-clonic in 29% (4 of 14), atonic in 22% (three of 14), and focal with motor signs in 14% (two of 14). All patients walked independently at the age of 12.0 (11.0-18.0) months, but delayed speech or regression of acquired verbal skills was present in 100% of patients at 3 years. EEGs revealed a photoparoxysmal response (PPR) on intermittent photic stimulation in 93% (13 of 14) of patients. PPR was present from the first EEG, which was performed at 3.6 (3.1-4.0) years, in 43% (six of 14) of patients; it was documented at low (1-3 Hz) stimulation frequencies in 69% (nine of 13) and took the form of a flash-per-flash response in 69% (nine of 13). First brain MRI at the age of 3.8 (3.0-5.1) years revealed cerebellar atrophy in 100% (14 of 14) of patients and alteration of the periventricular white matter signal in the posterior hemispheric region in 79% (11 of 14).

SIGNIFICANCE

Early photosensitivity (typically PPR at low stimulation frequencies of 1-3 Hz) is a hallmark of CLN2 disease. This diagnosis should be considered in a child presenting with any type of seizure, and particularly if it is accompanied by delayed speech and/or ataxia or MRI abnormalities (posterior white matter signal alteration or cerebellar atrophy).

摘要

目的

本研究旨在明确神经元蜡样脂褐质沉积症 2 型(CLN2)疾病的早期临床、磁共振成像(MRI)和脑电图(EEG)特征,以便进行早期诊断,从而为早期治疗提供关键,并优化护理和结局。

方法

对 2005 年至 2015 年期间在意大利一家单中心被诊断为 CLN2 疾病的一系列患者进行回顾性临床病历回顾。回顾了临床、MRI 和 EEG 发现。

结果

共纳入 14 例患者。对于整个组,疾病发病年龄的中位数(范围)为 3.0(2.0-3.8)岁。癫痫是最常见的首发症状(14 例患者中的 50%[7 例]),发病年龄为 3.2(2.6-3.8)岁。首次发作时,36%(14 例中的 5 例)为肌阵挛性,29%(14 例中的 4 例)为全面强直阵挛性,22%(14 例中的 3 例)为失张力性,14%(14 例中的 2 例)为局灶性伴运动体征。所有患者在 12.0(11.0-18.0)个月时能够独立行走,但在 3 岁时 100%(14 例中的 14 例)的患者存在语言延迟或已获得的语言技能退化。脑电图间歇性光刺激时发现光惊厥反应(PPR),在 93%(14 例中的 13 例)的患者中存在。PPR 存在于首次脑电图中,首次脑电图在 3.6(3.1-4.0)岁时进行,在 43%(14 例中的 6 例)的患者中存在;在 69%(13 例中的 9 例)中以低(1-3Hz)刺激频率记录到,在 69%(13 例中的 9 例)中以闪光-闪光反应的形式存在。在 3.8(3.0-5.1)岁时进行的首次脑 MRI 显示 100%(14 例中的 14 例)的患者存在小脑萎缩和后部半球区域的脑室周围白质信号改变。

意义

早期光敏性(通常为 1-3Hz 的低频刺激下的 PPR)是 CLN2 疾病的一个标志。如果患儿出现任何类型的癫痫发作,特别是伴有语言延迟和/或共济失调或 MRI 异常(后部白质信号改变或小脑萎缩),应考虑该诊断。

相似文献

1
Photosensitivity is an early marker of neuronal ceroid lipofuscinosis type 2 disease.光敏感性是神经元蜡样质脂褐质沉积症 2 型疾病的早期标志物。
Epilepsia. 2017 Aug;58(8):1380-1388. doi: 10.1111/epi.13820. Epub 2017 Jun 20.
2
Unique Characteristics of the Photoparoxysmal Response in Patients With Neuronal Ceroid Lipofuscinosis Type 2: Can EEG Be a Biomarker?2型神经元蜡样脂褐质沉积症患者光阵发性反应的独特特征:脑电图能否作为生物标志物?
J Child Neurol. 2016 Nov;31(13):1475-1482. doi: 10.1177/0883073816658659. Epub 2016 Jul 21.
3
Late-onset childhood neuronal ceroid lipofuscinosis: Early clinical and electroencephalographic markers.晚发型儿童神经元蜡样脂褐质沉积症:早期临床和脑电图标志物
Epilepsy Res. 2018 Aug;144:49-52. doi: 10.1016/j.eplepsyres.2018.05.005. Epub 2018 May 16.
4
Role of Electroencephalogram (EEG) and Magnetic Resonance Imaging (MRI) Findings in Early Recognition and Diagnosis of Neuronal Ceroid Lipofuscinosis Type 2 Disease.脑电图(EEG)和磁共振成像(MRI)检查结果在2型神经元蜡样脂褐质沉积症早期识别与诊断中的作用
J Child Neurol. 2022 Dec;37(12-14):984-991. doi: 10.1177/08830738221128773. Epub 2022 Oct 3.
5
[Clinical and electroencephalographic aspects of late infantile neuronal ceroid lipofuscinosis].[晚发性婴儿神经元蜡样脂褐质沉积症的临床及脑电图特征]
Rev Neurol. 2005;40(3):135-40.
6
Expanding the Neuroimaging Phenotype of Neuronal Ceroid Lipofuscinoses.扩展神经元蜡样脂褐质沉积症的神经影像学表型。
AJNR Am J Neuroradiol. 2020 Oct;41(10):1930-1936. doi: 10.3174/ajnr.A6726. Epub 2020 Aug 27.
7
Paediatric-onset neuronal ceroid lipofuscinosis: first symptoms and presentation at diagnosis.儿童起病神经元蜡样脂褐质沉积症:首发症状和诊断时表现。
Dev Med Child Neurol. 2020 Apr;62(4):528-530. doi: 10.1111/dmcn.14346. Epub 2019 Sep 5.
8
Unraveling neuronal ceroid lipofuscinosis type 2 (CLN2) disease: A tertiary center experience for determinants of diagnostic delay.解析神经元蜡样脂褐质沉积症 2 型(CLN2)疾病:三级中心诊断延迟决定因素的经验。
Eur J Paediatr Neurol. 2021 Jul;33:94-98. doi: 10.1016/j.ejpn.2021.05.015. Epub 2021 Jun 4.
9
Neuronal ceroid lipofuscinosis type 2: an Australian case series.神经元蜡样脂褐质沉积症 2 型:澳大利亚病例系列。
J Paediatr Child Health. 2020 Aug;56(8):1210-1218. doi: 10.1111/jpc.14890. Epub 2020 Apr 24.
10
New subform of the late infantile form of neuronal ceroid lipofuscinosis.神经元蜡样脂褐质沉积症晚期婴儿型的新亚型。
Neuropediatrics. 1993 Jun;24(3):155-63. doi: 10.1055/s-2008-1071534.

引用本文的文献

1
Early Symptoms and Treatment Outcomes in Neuronal Ceroid Lipofuscinosis Type 2: Croatian Experience.2型神经元蜡样脂褐质沉积症的早期症状与治疗结果:克罗地亚的经验
J Pers Med. 2024 Jul 24;14(8):783. doi: 10.3390/jpm14080783.
2
Ceroid lipofuscinosis type 2 disease: Effective presymptomatic therapy-Oldest case of a presymptomatic enzyme therapy.脑脂质沉积症 2 型疾病:有效的症状前治疗——首例症状前酶治疗。
Eur J Neurol. 2024 Sep;31(9):e16324. doi: 10.1111/ene.16324. Epub 2024 May 1.
3
Language Delay in Patients with CLN2 Disease: Could It Support Earlier Diagnosis?
CLN2 病患者的语言发育迟缓:是否有助于更早诊断?
Neuropediatrics. 2023 Dec;54(6):402-406. doi: 10.1055/s-0043-1770143. Epub 2023 Jun 17.
4
Clinical management and diagnosis of CLN2 disease: consensus of the Brazilian experts group.CLN2 病的临床管理和诊断:巴西专家组共识。
Arq Neuropsiquiatr. 2023 Mar;81(3):284-295. doi: 10.1055/s-0043-1761434. Epub 2023 Apr 14.
5
Buffy Coat Score as a Biomarker of Treatment Response in Neuronal Ceroid Lipofuscinosis Type 2.血沉棕黄层评分作为2型神经元蜡样脂褐质沉积症治疗反应的生物标志物
Brain Sci. 2023 Jan 27;13(2):209. doi: 10.3390/brainsci13020209.
6
Identification of a Q278X Mutation in an Iranian Patient with Neuronal Ceroid Lipofuscinosis 2: Literature Review and Mutations Update.一名患有2型神经元蜡样脂褐质沉积症的伊朗患者中Q278X突变的鉴定:文献综述与突变更新
J Clin Med. 2022 Oct 29;11(21):6415. doi: 10.3390/jcm11216415.
7
Genetic and phenotypic spectrum of Chinese patients with epilepsy and photosensitivity.中国癫痫伴光敏性患者的遗传学和表型谱
Front Neurol. 2022 Aug 2;13:907228. doi: 10.3389/fneur.2022.907228. eCollection 2022.
8
Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis.神经元蜡样脂褐质沉积症的遗传基础、临床特征和诊断方法的最新研究进展。
Int J Mol Sci. 2022 May 20;23(10):5729. doi: 10.3390/ijms23105729.
9
Neuronal Ceroid Lipofuscinosis: The Multifaceted Approach to the Clinical Issues, an Overview.神经元蜡样脂褐质沉积症:临床问题的多方面探讨,综述
Front Neurol. 2022 Mar 11;13:811686. doi: 10.3389/fneur.2022.811686. eCollection 2022.
10
Neurophysiological Findings in Neuronal Ceroid Lipofuscinoses.神经元蜡样脂褐质沉积症的神经生理学发现
Front Neurol. 2022 Feb 25;13:845877. doi: 10.3389/fneur.2022.845877. eCollection 2022.